The effectiveness of topiramate in comparison with acetazolamide in ?childre

Phase 3

• Conditions: External hydrocephalus.; Hydrocephalus, unspecified; G91.9

• Registration Number: IRCT20201105049278N1
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Being between 3 and 9 months old
Final diagnosis of external hydrocephalus based on clinical evidence and brain imaging
Normal status of cognitive motor development (based on interview and clinical examination)

Exclusion Criteria

Having a brain tumor and subdural hematoma
Symptoms of increased intracranial pressure
Abnormal cognitive motor development
Existence of internal hydrocephalus

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
External hydrocephalus. Timepoint: At the end of each month, the head circumference is measured and at the end of the 2-month treatment period, patients undergo Brain Sonography, and one month after the end of the 2-month drug intervention, patients are evaluated for external hydrocephalus. Method of measurement: Brain Sonography.